Background Venoarterial extracorporeal membrane oxygenation (V-A ECMO) use to support patients in cardiac failure is increasing. Despite this increased use, predicting successful weaning from ECMO can
Retrospective review of the Extracorporeal Life Support Registry from 2007 - 2017 of a subset of neonates with a primary diagnosis of meconium aspiration syndrome or primary pulmonary hypertension of
